OptimizeRx Corporation provided earnings guidance for the first quarter of 2024, for the quarter, the company expects revenue to increase over 40% year-over-year and come in between $18.5 million and $19.2 million with a GAAP net loss between $8.2 million - $7.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.72 USD | -2.82% | -9.43% | -18.10% |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | OptimizeRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-18.10% | 214M | |
+28.54% | 444B | |
+30.17% | 273B | |
+3.61% | 133B | |
+7.43% | 92.85B | |
+25.55% | 90.85B | |
+66.90% | 62.2B | |
+12.06% | 45.32B | |
+21.48% | 36.01B | |
-10.69% | 31.88B |
- Stock Market
- Equities
- OPRX Stock
- News OptimizeRx Corporation
- OptimizeRx Corporation Provides Earnings Guidance for the First Quarter of 2024